STERiJECT: FDA-cleared needle for precise intravitreal injections

In ophthalmology, fractions of a millimeter make all the difference. That’s where STERiJECT™, the FDA-cleared low-dead-space needle from TSK Laboratory, in collaboration with ACollaboratory America Inc., steps in by cutting waste, minimizing trauma and maximizing precision for intravitreal injections. From its ultra-sharp triple-bevel tip to its dolphin-nose glue dome, every detail is engineered for retinal specialists who demand control down to the microliter. Now cleared and clinic-ready, STERiJECT™ Ophthalmic Low Dead Space Needle brings precision you can feel. —Read the full article: https://lnkd.in/gCGp-St3 —See it up close at Booth #1024 at AAO 2025 This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore. American Academy of Ophthalmology #STERiJECT #TSK #AAO2025 #RetinaInnovation #IntravitrealInjection #Ophthalmology

To view or add a comment, sign in

Explore content categories